Inventor
VISWANADHA SRIKANT
IN39 patents
⚠️ This page may combine multiple inventors who share the name “VISWANADHA SRIKANT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
RHIZEN PHARMACEUTICALS SA
28 patentsUS9737521B2Aug 22, 2017
Pharmaceutical compositions containing a PDE4 inhibitor and a PI3 delta or dual PI3 delta-gamma kinase inhibitor
RHIZEN PHARMACEUTICALS SA4 citations84
US9018375B2Apr 28, 2015
Substituted chromenes as kinase modulators
RHIZEN PHARMACEUTICALS SA8 citations83
US8921364B2Dec 30, 2014
Modulators of calcium release-activated calcium channel
RHIZEN PHARMACEUTICALS SA7 citations82
US8377970B2Feb 19, 2013
Modulators of calcium release-activated calcium channel
RHIZEN PHARMACEUTICALS SA7 citations82
US9421209B2Aug 23, 2016
Kinase modulators
RHIZEN PHARMACEUTICALS SA3 citations73
US10220035B2Mar 5, 2019
Compounds as modulators of protein kinases
RHIZEN PHARMACEUTICALS SA2 citations72
US9815831B2Nov 14, 2017
3,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of c-Met protein kinases
RHIZEN PHARMACEUTICALS SA5 citations71
US9783533B2Oct 10, 2017
Glutaminase inhibitors
RHIZEN PHARMACEUTICALS SA4 citations69
US11858907B2Jan 2, 2024
Kinase modulators
RHIZEN PHARMACEUTICALS SA0 citations62
US11466006B2Oct 11, 2022
Dual selective PI3 delta and gamma kinase inhibitors
RHIZEN PHARMACEUTICALS SA0 citations62
US11065236B2Jul 20, 2021
Pharmaceutical compositions containing a PDE4 inhibitor and a PI3 delta or dual PI3 delta-gamma kinase inhibitor
RHIZEN PHARMACEUTICALS SA0 citations62
US11020399B2Jun 1, 2021
Intermediates useful in the synthesis of compounds as modulators of protein kinases
RHIZEN PHARMACEUTICALS SA0 citations62
US11066402B2Jul 20, 2021
3,5-disubstituted-3H-imidazo[4,5-b]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of c-Met protein kinases
RHIZEN PHARMACEUTICALS SA0 citations61
US9758514B2Sep 12, 2017
Modulators of calcium release-activated calcium channel
RHIZEN PHARMACEUTICALS SA1 citations61
US10538501B2Jan 21, 2020
Kinase modulators
RHIZEN PHARMACEUTICALS SA0 citations52
US10413532B2Sep 17, 2019
Pharmaceutical compositions containing a PDE4 inhibitor and a PI3 delta or dual PI3 delta-gamma kinase inhibitor
RHIZEN PHARMACEUTICALS SA0 citations52
US10058539B2Aug 28, 2018
Pharmaceutical compositions containing a PDE4 inhibitor and a PI3 delta or dual PI3 delta-gamma kinase inhibitor
RHIZEN PHARMACEUTICALS SA0 citations52
US10851107B2Dec 1, 2020
Dual selective P13 delta and gamma kinase inhibitors
RHIZEN PHARMACEUTICALS SA0 citations51
US10668051B2Jun 2, 2020
Modulators of calcium release-activated calcium channel
RHIZEN PHARMACEUTICALS SA0 citations51
US10322130B2Jun 18, 2019
Substituted chromenones as modulators of protein kinases
RHIZEN PHARMACEUTICALS SA0 citations51
US10246450B2Apr 2, 2019
Modulators of calcium release-activated calcium channel
RHIZEN PHARMACEUTICALS SA0 citations51
US9944631B2Apr 17, 2018
Modulators of calcium release-activated calcium channel
RHIZEN PHARMACEUTICALS SA0 citations51
US9777018B2Oct 3, 2017
Compounds as modulators of GPR-119
RHIZEN PHARMACEUTICALS SA1 citations51
US9758474B2Sep 12, 2017
Immunomodulator and anti-inflammatory compounds
RHIZEN PHARMACEUTICALS SA1 citations51
US10611759B2Apr 7, 2020
Glutaminase inhibitors
RHIZEN PHARMACEUTICALS SA0 citations50
US9790224B2Oct 17, 2017
Dual selective PI3 delta and gamma kinase inhibitors
RHIZEN PHARMACEUTICALS SA0 citations50
US10786504B2Sep 29, 2020
Method of treatment and compositions comprising a dual PI3K delta-gamma kinase inhibitor and a corticosteroid
RHIZEN PHARMACEUTICALS SA0 citations49
US10174034B2Jan 8, 2019
Modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer
RHIZEN PHARMACEUTICALS SA0 citations47
MUTHUPPALANIAPPAN MEYYAPPAN
5 patentsUS8642607B2Feb 4, 2014
4H-chromen-4-one compounds as modulators of protein kinases
MUTHUPPALANIAPPAN MEYYAPPAN17 citations91
US8481739B2Jul 9, 2013
3,5-Disubstituted-3H-imidazo[4,5-b]pyridine and 3,5-disubstituted-3H[1,2,3]triazolo [4,5-b] Pyridine Compounds as Modulators of protein kinases
MUTHUPPALANIAPPAN MEYYAPPAN7 citations83
US8993612B2Mar 31, 2015
Modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer
MUTHUPPALANIAPPAN MEYYAPPAN6 citations79
US10442783B2Oct 15, 2019
2,3-disubstituted chromen-4-one compounds as modulators of protein kinases
MUTHUPPALANIAPPAN MEYYAPPAN0 citations51
US8686048B2Apr 1, 2014
Immunomodulator and anti-inflammatory compounds
MUTHUPPALANIAPPAN MEYYAPPAN1 citations50
INCOZEN THERAPEUTICS PVT LTD
3 patentsUS8912331B2Dec 16, 2014
3,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of protein kinases
INCOZEN THERAPEUTICS PVT LTD17 citations91
US10087182B2Oct 2, 2018
3,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of protein kinases
INCOZEN THERAPEUTICS PVT LTD3 citations72
US10590129B2Mar 17, 2020
3,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of protein kinases
INCOZEN THERAPEUTICS PVT LTD0 citations51